ReviewJournal of clinical medicine2023

Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib.

Robert Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.